Discovery of novel anti-tumor curcumin analogues from the optimization of curcumin scaffold
Abstract
A series of novel curcumin analogues were synthesized by optimization of its aromatic ring. The antiproliferative activities of these analogues were screened against four human cancer cell lines by MTT assay and some displayed significant improvement in antiproliferative activity compared with curcumin. The most potent compound 10 exhibited antiproliferative activity against Caco-2, Bel-7402, MDA-MB-231, and DU145 cancer cells with IC50 values of 2.04, 1.54, 4.99, and 3.22 μM, respectively. Annexin V/propidium iodide double staining and flow cytometry cell cycle analysis using propidium iodide DNA staining revealed that compound 10 induced apoptosis and cell cycle arrest at G1 phase in Bel-7402 cells in a dose-dependent manner. Moreover, in an in vivo mouse model of liver cancer xenograft, compound 10 substantially inhibited liver tumor growth at a dose of 20 mg/kg/day without observable toxic effect.
Publisher URL: https://link.springer.com/article/10.1007/s00044-017-1946-2
DOI: 10.1007/s00044-017-1946-2
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.